Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia

NCT01003769 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Recurrent Chronic Lymphocytic Leukemia

Interventions

DRUG: Lenalidomide
DRUG: R-(-)-Gossypol Acetic Acid
OTHER: Laboratory Biomarker Analysis

Sponsor

Mayo Clinic

Collaborators

[object Object]